<code id='E7D214A7D2'></code><style id='E7D214A7D2'></style>
    • <acronym id='E7D214A7D2'></acronym>
      <center id='E7D214A7D2'><center id='E7D214A7D2'><tfoot id='E7D214A7D2'></tfoot></center><abbr id='E7D214A7D2'><dir id='E7D214A7D2'><tfoot id='E7D214A7D2'></tfoot><noframes id='E7D214A7D2'>

    • <optgroup id='E7D214A7D2'><strike id='E7D214A7D2'><sup id='E7D214A7D2'></sup></strike><code id='E7D214A7D2'></code></optgroup>
        1. <b id='E7D214A7D2'><label id='E7D214A7D2'><select id='E7D214A7D2'><dt id='E7D214A7D2'><span id='E7D214A7D2'></span></dt></select></label></b><u id='E7D214A7D2'></u>
          <i id='E7D214A7D2'><strike id='E7D214A7D2'><tt id='E7D214A7D2'><pre id='E7D214A7D2'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:831
          An FDA sign — health policy coverage from STAT
          Sarah Silbiger/Getty Images

          WASHINGTON — There’s about to be a new acronym in town.

          The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

          advertisement

          That overhaul includes a new name: Meet the Office of Inspections and Investigations.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Pharma patents targeted by Biden in move to slash drug prices
          Pharma patents targeted by Biden in move to slash drug prices

          PresidentBidenMANDELNGAN/AFPviaGettyImagesWASHINGTON—TheWhiteHouseisthrowingitssupportbehindacontrov

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          SEC charges former device maker CEO with $41 million fraud

          From2017to2020,Stimwaveimplantednearly8,000patientswithnervestimulatorscontainingdummypiecesofplasti